6506--VAPAHCS Human Blood and Blood Related Products
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the VA Palo Alto Health Care System (VAPAHCS), is soliciting proposals for Human Blood and Blood Related Products. This is an Unrestricted acquisition for a Firm-Fixed-Price, Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract. The requirement includes providing various blood components and related services, adhering to strict regulatory standards. Proposals are due January 26, 2026, at 12 PM MST.
Scope of Work
The contractor will provide human blood, blood components, and associated services to VAPAHCS. This includes ensuring strict adherence to all current Food and Drug Administration (FDA) guidelines for blood collection and processing, American Association of Blood Banks (AABB) standards, and California state regulations. Key requirements involve specific bacteria risk control methods (e.g., LVDS or pathogen reduction), comprehensive testing for infectious diseases (syphilis, HIV, Hepatitis B/C, HTLV, West Nile Virus), and specific shelf-life and age limits for products. Services encompass screening for antigen-negative blood, irradiation, CMV-negative screening, freezing/storing/thawing autologous blood, plateletpheresis, crossmatching, antibody identification, and HLA typing. All blood must be from 100% volunteer donors. Delivery timelines are critical, with STAT/Emergency orders requiring delivery within one hour to the VA Palo Alto Blood Bank.
Contract Details
- Contract Type: Firm-Fixed-Price, Indefinite-Delivery, Indefinite-Quantity (IDIQ)
- Period of Performance: Five ordering periods, commencing June 1, 2026, and concluding September 30, 2030.
- Estimated Value: Guaranteed Minimum of $100.00, with a Maximum Aggregate Value of $6,000,000.00.
- Set-Aside: Unrestricted
- NAICS Code: 621991 (Blood and Organ Banks)
- Size Standard: $40 Million
Submission & Evaluation
Offerors must submit their proposals via email to David.alvarez4@va.gov and tawnya.krommenhoek@va.gov. The submission must include the completed 36C26126DXXXX_PRICE LIST.xlsx (V2) with pricing and part numbers for the five ordering periods, along with the signed RFQ. Submissions should not be made through SAM.gov. Evaluation will be a comparative process based on conformance with the Statement of Work and Price List, overall Price, and Distribution Location, leading to a best value determination for a single award IDIQ contract.
Key Updates
An amendment has extended the proposal due date to January 26, 2026, at 12 PM MST. It also clarified that the volume for Autologous RBCs is 15 units, not 1400, and confirmed that HLA-specific product orders primarily originate from the Transplant/Cardiology Department. Bidders are permitted to adjust the pricing spreadsheet by adding or removing products/services, provided they highlight any changes made.
Contact Information
For inquiries, contact Tawnya S Krommenhoek, Contract Specialist, at tawnya.krommenhoek@va.gov.